Monday, May 23, 2016
08.30 - 10.00 | Concurrent Symposia S09 - S12 |
S09. Debating germline genome editing - joint with EMPAG and ASHG (Plenary Hall)S09.1 Technical opportunities of genome editing S09.2 Clinical aspects of germline genome editing S09.3 Ethical aspect of germline gene editing S09.4 ASHG statement on germline genome editing S10. Brain genetics (Room 112)S10.1 The genetics of brain calcification S10.2 RNA processing defects and neurodegenerative diseases S10.3 Inflammation, atherosclerosis and Alzheimer disease S11. Human genomics: transcriptome, proteome and interactome (Room 117)S11.1 The human transcriptome across tissues and individuals S11.2 Differential DNA mismatch repair underlies mutation rate variation across the human genome S11.3 Mapping Human Long Noncoding RNAs S12. SeX and the citY (Room 113+114)S12.1 Sex determination: why so many ways of doing it? S12.2 Origins and functional evolution of Y chromosomes across mammals S12.3 A Y-like social chromosome causes alternative colony organization in fire ants |
08.30 - 10.00 | Educational Session 7 |
E7. Cleaning the noise from Big Data (Room 115+116)E07.1 Removing "unwanted variation" in sequence data E07.2 Opportunities for Scaling Up Genetic Analysis | |
| 10.00 - 10.15 | Coffee Break, Exhibition |
10.15 - 11.15 | Poster Viewing with Authors - Group C |
11.15 - 13.00 | Free Poster Viewing, Exhibition, Lunch break |
11.15 - 12.45 | Corporate Satellites |
13.00 - 14.30 | Concurrent Sessions C13 - C18 - Click on the titles for details |
C13 Prenatal Genetics and carrier screening (Plenary Hall) | |
| 14.30 - 15.00 | Fruit Break, Free Poster Viewing, Exhibition |
15.00 - 16.30 | Workshops W12 - W18 - Click on the titles to see detailed programmes |
W12. European landscape of non-invasive prenatal diagnosis (Plenary Hall) |
15.00 - 16.30 | Corporate Satellites |
| 16.30 - 16.45 | Coffee Break, Free Poster Viewing, Exhibition |
16.45 - 17.45 | Poster Viewing with Authors - Group D |
17.45 - 19.15 | Concurrent Symposia S13 - S16 |
S13.Epigenetic reprogramming in disease (Plenary Hall)S13.1 Epigenetic regulation of cancer progression S13.2 Intergenerational and Stochastic Epigenetic Control of Metabolic Disease: Evidence for polyphenism in mouse and man? S13.3 Epigenetic reprogramming in the germline and early embryo S14. Reproductive genetics and genomics (Room 112)S14.1 Cell fate decisions during early development S14.2 Human Embryo Genome Activation S14.3 Mechanisms of lineage specification in human embryos and stem cells S15. Therapy in rare diseases (Room 117)S15.1 Gene therapy in Fanconi anemia S15.2 Antisense therapy in Spinal Muscular Atrophy S15.3 Novel Approaches to the Treatment of Cystic fibrosis S16. Cardiovascular genetics - joint with ESC (Room 113+114)S16.1 Update on the genetics of thoracic aortic aneurysms S16.2 Genetics of spontaneous cervical artery dissection S16.3 Molecular mechanisms responsible for inherited hypertension with brachydactyly |
17.45 - 19.15 | Educational Session 8 |
E8. Clinical interpretation of genetic variants (Room 115+116)E08.1 Methods for the assessment of variant pathogenicity in cardiac diseases E08.2 The ACMGG recommendations for the interpretation of genetic variants | |
20.30 | Networking Evening at the Pueblo Español |